Education
About Us
Working with TipRanks
Follow Us
Xintela AB (SE:XINT)
:XINT
Vehicle, Xstem-Vlu
Venous Leg Ulcer
Phase I/II
Recruiting
A Study of XSTEM-VLU in Patients With Difficult-to-heal Venous Leg Ulcers
Sep 06, 2022
―
Xstem-Oa
Osteoarthritis, Knee
Phase I/II
Completed
A First-in-Human Study of XSTEM-OA in Patients With Knee Osteoarthritis
Apr 04, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Xintela AB (XINT) have in its pipeline
XINT is currently developing the following drugs: Vehicle, Xstem-Vlu, Xstem-Oa. These drug candidates are in various stages of clinical development as the company works toward FDA approval.